Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF), a specialist in rapid health screening solutions using artificial intelligence (AI), has announced a groundbreaking collaborative agreement with Digital Medical Experts Inc. that aims to enhance mental health diagnostics and treatment by leveraging the pair's advanced technologies.
It will focus on key areas such as advanced diagnostic capabilities, holistic mental health assessment, suicide risk assessment, early intervention, and comprehensive mood analysis.
Digital Medical Experts brings to the table its expertise in analyzing brain electrical activity patterns, while Predictmedix AI specializes in detecting signs of depression, anxiety, and mood changes through hyperspectral facial image analysis.
Both organizations said they are committed to integrating their unique capabilities to develop comprehensive mental health solutions.
This includes sharing anonymized data to improve AI algorithms, collaborating on research and development, and exploring telehealth integration for remote, personalized care. The plan is also to conduct clinical trials to validate the effectiveness of their combined technologies in real-world scenarios.
"This collaboration propels mental health diagnostics into a new era, combining precision and a holistic approach for individual mental well-being," said Dr Rahul Kushwah, chief operating officer of Predictmedix AI.